{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:29:14Z","timestamp":1757701754304},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,4,12]],"date-time":"2005-04-12T00:00:00Z","timestamp":1113264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,4,12]],"date-time":"2005-04-12T00:00:00Z","timestamp":1113264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>The interest of patients in participating in randomized clinical trials involving treatments has been widely studied, but there has been much less research on interest in preventive trials. The objective of this study was to find out how many women would be interested in a trial involving postmenopausal hormone therapy (PHT) and how the women's background characteristics and opinions correlated to their interest.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>The data come from recruitment questionnaires (n = 2000) sent to women in Estonia in 1998. A random sample of women aged 45 to 64 was drawn from the Population Registry. The trial is a two-group randomized trial comparing estrogen-progestogen therapy with placebo or no drugs. A brief description of the study was attached to the questionnaires. Women were not told at this stage of the recruitment which group they would be assigned to, however, they were told of the chance to receive either hormone, placebo or no treatment.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>After two reminders, 1312 women (66%) responded. Eleven percent of the women approached (17% of the respondents) were interested in joining the trial, and 8% wanted more information before deciding. When the 225 women who stated clearly that they were interested in joining and the 553 women who said they were not interested were compared, it was found that interested women were younger and, adjusting for age, that more had given birth; in other respects, the sociodemographic characteristics and health habits of the interested women were similar to those of the non-interested women. The interested women had made more use of more health services, calcium preparations and PHT, they were more often overweight, and more had chronic diseases and reported symptoms. Interested women's opinions on the menopause were more negative, and they favoured PHT more than the non-interested women.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Unlike the situation described in previous reports on preventive trials, in this case Estonian women interested in participating in a PHT trial were not healthier than other women. This suggests that trials involving PHT are more similar to treatment trials than to preventive trials. In a randomized controlled trial, more information should be obtained from those women who decline to participate.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-2288-5-12","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T14:31:46Z","timestamp":1113402706000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Who wants to join preventive trials? \u2013 Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]"],"prefix":"10.1186","volume":"5","author":[{"given":"Sirpa-Liisa","family":"Hovi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Hakama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piret","family":"Veerus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mati","family":"Rahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elina","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,12]]},"reference":[{"key":"100_CR1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/135581969900400210","volume":"4","author":"A Britton","year":"1999","unstructured":"Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C: Threats to applicability of randomised trials: exclusions and selective participation. Journal of Health Services & Research Policy. 1999, 4: 112-121.","journal-title":"Journal of Health Services & Research Policy"},{"key":"100_CR2","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0895-4356(99)00141-9","volume":"52","author":"S Ross","year":"1999","unstructured":"Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R: Barriers to participation in randomised controlled trials: a systematic review.[see comment]. Journal of Clinical Epidemiology. 1999, 52: 1143-1156. 10.1016\/S0895-4356(99)00141-9.","journal-title":"Journal of Clinical Epidemiology"},{"key":"100_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1023\/A:1008342222205","volume":"11","author":"PM Ellis","year":"2000","unstructured":"Ellis PM: Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Annals of Oncology. 2000, 11: 939-945. 10.1023\/A:1008342222205.","journal-title":"Annals of Oncology"},{"key":"100_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/(SICI)1097-4644(2000)77:34+<80::AID-JCB14>3.0.CO;2-E","volume":"34","author":"MT Ruffin 4th","year":"2000","unstructured":"Ruffin MT, Baron J: Recruiting subjects in cancer prevention and control studies. Journal of Cellular Biochemistry - Supplement. 2000, 34: 80-83.","journal-title":"Journal of Cellular Biochemistry - Supplement"},{"key":"100_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1369-6513.1999.00028.x","volume":"2","author":"PM Ellis","year":"1999","unstructured":"Ellis PM, Dowsett SM, Butow PN, Tattersall MH: Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic. Health Expect. 1999, 2: 33-43. 10.1046\/j.1369-6513.1999.00028.x.","journal-title":"Health Expect"},{"key":"100_CR6","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/S0959-8049(98)00193-2","volume":"34","author":"LJ Fallowfield","year":"1998","unstructured":"Fallowfield LJ, Jenkins V, Brennan C, Sawtell M, Moynihan C, Souhami RL: Attitudes of patients to randomised clinical trials of cancer therapy. Eur J Cancer. 1998, 34: 1554-1559. 10.1016\/S0959-8049(98)00193-2.","journal-title":"Eur J Cancer"},{"key":"100_CR7","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/bmj.317.7167.1177","volume":"317","author":"K Featherstone","year":"1998","unstructured":"Featherstone K, Donovan JL: Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. Bmj. 1998, 317: 1177-1180.","journal-title":"Bmj"},{"key":"100_CR8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/S0277-9536(97)00063-4","volume":"45","author":"C Snowdon","year":"1997","unstructured":"Snowdon C, Garcia J, Elbourne D: Making sense of randomization; responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Soc Sci Med. 1997, 45: 1337-1355. 10.1016\/S0277-9536(97)00063-4.","journal-title":"Soc Sci Med"},{"key":"100_CR9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/135581969600100403","volume":"1","author":"DJ Torgerson","year":"1996","unstructured":"Torgerson DJ, Klaber-Moffett J, Russell IT: Patient preferences in randomised trials: threat or opportunity?. J Health Serv Res Policy. 1996, 1: 194-197.","journal-title":"J Health Serv Res Policy"},{"key":"100_CR10","doi-asserted-by":"publisher","first-page":"6S","DOI":"10.1016\/0197-2456(87)90004-3","volume":"8","author":"DB Hunninghake","year":"1987","unstructured":"Hunninghake DB, Darby CA, Probstfield JL: Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials. 1987, 8: 6S-30S. 10.1016\/0197-2456(87)90004-3.","journal-title":"Control Clin Trials"},{"key":"100_CR11","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/bmj.309.6968.1553","volume":"309","author":"G Davies","year":"1994","unstructured":"Davies G, Pyke S, Kinmonth AL: Effect of non-attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. Family Heart Study Group. Bmj. 1994, 309: 1553-1556.","journal-title":"Bmj"},{"key":"100_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/02813439409029249","volume":"12","author":"GK Naslund","year":"1994","unstructured":"Naslund GK, Fredrikson M, Hellenius ML, de Faire U: Characteristics of participating and nonparticipating men in a randomized, controlled diet and exercise intervention trial. Scand J Prim Health Care. 1994, 12: 249-254.","journal-title":"Scand J Prim Health Care"},{"key":"100_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/1097-0142(19950701)76:1<46::AID-CNCR2820760107>3.0.CO;2-B","volume":"76","author":"A Yeomans-Kinney","year":"1995","unstructured":"Yeomans-Kinney A, Vernon SW, Frankowski RF, Weber DM, Bitsura JM, Vogel VG: Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment. Cancer. 1995, 76: 46-56.","journal-title":"Cancer"},{"key":"100_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1532-5415.1996.tb06405.x","volume":"44","author":"JT Pacala","year":"1996","unstructured":"Pacala JT, Judge JO, Boult C: Factors affecting sample selection in a randomized trial of balance enhancement: the FICSIT Study. J Am Geriatr Soc. 1996, 44: 377-382.","journal-title":"J Am Geriatr Soc"},{"key":"100_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1023\/A:1014598332211","volume":"27","author":"BJ Shelton","year":"2002","unstructured":"Shelton BJ, Wofford JL, Gosselink CA, McClatchey MW, Brekke K, Conry C, Wolfe P, Cohen SJ: Recruitment and retention of physicians for primary care research. J Community Health. 2002, 27: 79-89. 10.1023\/A:1014598332211.","journal-title":"J Community Health"},{"key":"100_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0277-9536(99)00477-3","volume":"51","author":"JA Wragg","year":"2000","unstructured":"Wragg JA, Robinson EJ, Lilford RJ: Information presentation and decisions to enter clinical trials: a hypothetical trial of hormone replacement therapy. Soc Sci Med. 2000, 51: 453-462. 10.1016\/S0277-9536(99)00477-3.","journal-title":"Soc Sci Med"},{"key":"100_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.maturitas.2003.11.004","volume":"49","author":"SL Hovi","year":"2004","unstructured":"Hovi SL, Karttunen T, Karro H, Hemminki E: Comparison of Estonian and Finnish physicians' opinions of menopause and hormone therapy. Maturitas. 2004, 49: 107-113. 10.1016\/j.maturitas.2003.11.004.","journal-title":"Maturitas"},{"key":"100_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/sim.4780130518","volume":"13","author":"JH Ellenberg","year":"1994","unstructured":"Ellenberg JH: Selection bias in observational and experimental studies. Statistics in Medicine. 1994, 13: 557-567.","journal-title":"Statistics in Medicine"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-5-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-2288-5-12\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-5-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-5-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:14:13Z","timestamp":1728306853000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/1471-2288-5-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,12]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["100"],"URL":"https:\/\/doi.org\/10.1186\/1471-2288-5-12","relation":{},"ISSN":["1471-2288"],"issn-type":[{"type":"electronic","value":"1471-2288"}],"subject":[],"published":{"date-parts":[[2005,4,12]]},"assertion":[{"value":"13 September 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}